Hrt Financial LP Aquestive Therapeutics, Inc. Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$2.01 - $6.09 $573,573 - $1.74 Million	285,360 New	285,360 $1.22 Million
Q3 2021 Nov 15, 2021	SELL	$3.25 - $4.66 $162,197 - $232,566	-49,907 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.29 - $5.21 $164,194 - $260,015	49,907 New	49,907 $198,000
Q1 2021 May 17, 2021	SELL	$4.17 - $6.73 $81,402 - $131,376	-19,521 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$4.65 - $7.79 $90,772 - $152,068	19,521 New	19,521 $104,000

42.7M

271K

212K

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $252M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.